跳至主要内容
临床试验/IRCT20170611034458N3
IRCT20170611034458N3招募中3 期

The effect of crocin supplementation on glycemic control, inflammatory factors, oxidative stress biomarkers, glomerular and tubular markers in patients with diabetic nephropathy: A randomized controlled clinical trial

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 75 years(—)
性别
All

入选标准

  • Patients with diabetic nephropathy aged 40 to 75 years
  • Moderate blood pressure (systolic pressure 140-160 and diastolic pressure 90-100 mm Hg)
  • Absence of urinary tract infection and any other disease that can cause proteinuria
  • Glomerular filtration rate more than 60 milliliters per minute.

排除标准

  • Taking antioxidant supplements from three months before entering the study.
  • Patients who do not want to participate in the study or do not take medication regularly.
  • Taking steroidal immunosuppressive drugs (corticosteroids).
  • Suffering from certain cardiovascular diseases, cancer, inflammatory diseases, autoimmune disorders, or hyper- or hypothyroidism.
  • Taking anticoagulants.
  • Having high blood pressure (systolic pressure above 140 and diastolic pressure above 90 mm Hg).
  • Smoking and alcohol use

研究者

相似试验